RNMeta-AnalysisHeart & lung : the journal of critical care2021

Mortality of right ventricular dysfunction in patients with acute respiratory distress syndrome subjected to lung protective ventilation: A systematic review and meta-analysis.

Daoran Dong, Yuan Zong, Zhuo Li and 2 others

PMID 34118786

WHAT IT FOUND

In ARDS patients receiving lung-protective ventilation, right ventricular dysfunction or pulmonary vascular dysfunction was linked to higher mortality.

The link was clear for acute cor pulmonale, but not for pulmonary vascular dysfunction or mild right ventricular dysfunction alone.

Key findings

01The pooled odds ratio for mortality was 1.68 (95% CI 1.21-2.32) in 12 studies of 2319 ARDS patients. The authors report significantly elevated mortality risk with right ventricular dysfunction or pulmonary vascular dysfunction.

02In the subgroup analysis, acute cor pulmonale was associated with death (OR 1.57, 95% CI 1.09-2.25, P = 0.015).

03In the subgroup analysis, pulmonary vascular dysfunction or mild right ventricular dysfunction was not associated with death (OR 1.75, 95% CI 0.81-3.75, P = 0.165).

STILL TO COME

How it was doneWhat they foundWhat it means for RNs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

The review pooled observational studies, so it cannot prove that right ventricular dysfunction caused death. Some included studies had baseline differences in age and SOFA score, which may have made the groups less comparable. The studies used different definitions of right ventricular dysfunction and different diagnostic methods, including echocardiography and pulmonary artery catheterization. Some studies had small samples or lower quality, which may have affected the pooled estimate. The subgroup with pulmonary vascular dysfunction or mild right ventricular dysfunction had a wide confidence interval, so the lack of association is uncertain. All patients were receiving lung-protective ventilation, so the results may not apply to ARDS patients managed with other ventilation strategies. The review did not test whether right ventricular monitoring, prone positioning, nitric oxide, or other treatments changed mortality.

Declared interests

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

The easy way to misread this

Do not read the higher odds of death as proof that treating right ventricular dysfunction will reduce mortality. The included studies were observational, and the subgroup with pulmonary vascular dysfunction or mild right ventricular dysfunction did not show an association.

Read it on PubMed →